Free Trial

NewGenIvf Group (NIVF) Competitors

$1.23
+0.05 (+4.24%)
(As of 05/30/2024 ET)

NIVF vs. WWAC, NVNI, CERO, ZOOZ, QFTA, BENF, RWOD, EFHT, PBM, and HAIA

Should you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Worldwide Webb Acquisition (WWAC), Nvni Group (NVNI), CERo Therapeutics (CERO), ZOOZ Power (ZOOZ), Quantum FinTech Acquisition (QFTA), Beneficient (BENF), Redwoods Acquisition (RWOD), EF Hutton Acquisition Co. I (EFHT), Psyence Biomedical (PBM), and Healthcare AI Acquisition (HAIA). These companies are all part of the "holding & other investment offices" industry.

NewGenIvf Group vs.

Worldwide Webb Acquisition (NASDAQ:WWAC) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap unclassified companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, community ranking, risk, analyst recommendations and valuation.

In the previous week, NewGenIvf Group had 4 more articles in the media than Worldwide Webb Acquisition. MarketBeat recorded 4 mentions for NewGenIvf Group and 0 mentions for Worldwide Webb Acquisition. Worldwide Webb Acquisition's average media sentiment score of 1.23 beat NewGenIvf Group's score of 0.00 indicating that NewGenIvf Group is being referred to more favorably in the news media.

Company Overall Sentiment
Worldwide Webb Acquisition Neutral
NewGenIvf Group Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Worldwide Webb AcquisitionN/AN/AN/AN/AN/A
NewGenIvf GroupN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Worldwide Webb AcquisitionN/A N/A N/A
NewGenIvf Group N/A N/A N/A

49.1% of Worldwide Webb Acquisition shares are owned by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are owned by institutional investors. 43.0% of Worldwide Webb Acquisition shares are owned by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Worldwide Webb Acquisition has a beta of 0.07, suggesting that its stock price is 93% less volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500.

Worldwide Webb Acquisition and NewGenIvf Group both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Worldwide Webb AcquisitionN/AN/A
NewGenIvf GroupN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Worldwide Webb Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
NewGenIvf Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

NewGenIvf Group beats Worldwide Webb Acquisition on 4 of the 5 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NIVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NIVF vs. The Competition

MetricNewGenIvf GroupHolding Offices IndustryMedical SectorNASDAQ Exchange
Market Cap$4.59M$361.64M$5.04B$7.96B
Dividend YieldN/A7.56%2.84%3.99%
P/E RatioN/A5.07165.9818.23
Price / SalesN/A9.582,437.8970.15
Price / CashN/A60.2835.0631.24
Price / BookN/A82.685.584.64
Net IncomeN/A$23.73M$105.68M$213.60M
7 Day Performance16.04%-0.11%0.89%1.02%
1 Month Performance-29.71%-1.82%3.03%3.89%
1 Year PerformanceN/A-1.40%6.15%7.72%

NewGenIvf Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WWAC
Worldwide Webb Acquisition
0 of 5 stars
$1.44
+2.9%
N/AN/A$15.07MN/A0.002,021Gap Up
NVNI
Nvni Group
3.0014 of 5 stars
$1.42
-2.7%
$5.00
+252.1%
N/A$14.27MN/A0.00N/AShort Interest ↑
CERO
CERo Therapeutics
0 of 5 stars
$0.92
-2.1%
N/AN/A$13.82MN/A0.008Positive News
Gap Up
ZOOZ
ZOOZ Power
0 of 5 stars
$2.26
-7.4%
N/AN/A$13.55MN/A0.00N/AGap Up
QFTA
Quantum FinTech Acquisition
0 of 5 stars
$1.12
+0.9%
N/A-88.1%$11.29MN/A0.00N/AGap Up
High Trading Volume
BENF
Beneficient
0 of 5 stars
$3.15
-3.4%
N/AN/A$10.88M$-74,272,000.000.00150Short Interest ↑
Gap Up
RWOD
Redwoods Acquisition
0 of 5 stars
$6.08
+14.5%
N/A-45.4%$10.70MN/A0.00N/AShort Interest ↓
Positive News
Gap Down
EFHT
EF Hutton Acquisition Co. I
0 of 5 stars
$1.15
flat
N/A-88.9%$7.62MN/A0.00N/A
PBM
Psyence Biomedical
0 of 5 stars
$0.83
flat
N/AN/A$7.29MN/A0.00N/APositive News
Gap Down
HAIA
Healthcare AI Acquisition
0 of 5 stars
$11.14
+0.4%
N/A+6.0%$6.59MN/A0.002,021Short Interest ↑
News Coverage

Related Companies and Tools

This page (NASDAQ:NIVF) was last updated on 5/31/2024 by MarketBeat.com Staff

From Our Partners